Related content

Striatal dopamine D₂ receptor density in neuroleptic-naive and in neuroleptic-free schizophrenic patients: an ¹²³I-IBZM-SPECT study

By Lomeña Francisco   Catafau Ana   Parellada Eduard   Bernardo Miquel   Font Mireia   Gutiérrez Fernando   Pavía Javier  

Psychopharmacology, Vol. 172, Iss. 2, 2004-03 ,pp. : 165-169

Springer Publishing Company

Access to resources Recommend Favorite

Antipsychotic-induced extrapyramidal symptoms in patients with schizophrenia: associations with dopamine and serotonin receptor and transporter polymorphisms

By Güzey Cüneyt   Scordo Maria   Spina Edoardo   Landsem Veslemøy   Spigset Olav  

European Journal of Clinical Pharmacology, Vol. 63, Iss. 3, 2007-03 ,pp. : 233-241

Springer Publishing Company

Access to resources Recommend Favorite

Molecular modeling of serotonin, ketanserin, ritanserin and their 5-HT 2C receptor interactions

By Kristiansen K.   Dahl S.G.  

European Journal of Pharmacology, Vol. 306, Iss. 1, 1996-06 ,pp. : 195-210

Elsevier

Access to resources Recommend Favorite

Serotonin 2A receptor antagonists for treatment of schizophrenia

By Ebdrup Bjøørn H   Rasmussen Hans   Arnt Jøørn   Glenthøøj Birte  

Expert Opinion on Investigational Drugs, Vol. 20, Iss. 9, 2011-09 ,pp. : 1211-1223

Informa Healthcare

Access to resources Recommend Favorite

Effects of the 5-HT 2C2B receptor agonist 1-(3-chlorophenyl)piperazine on plasma glucose levels of rats

By Sugimoto Y.   Yamada J.   Yoshikawa T.   Horisaka K.  

European Journal of Pharmacology, Vol. 307, Iss. 1, 1996-06 ,pp. : 75-80

Elsevier

Access to resources Recommend Favorite